Evidence map›Paper›PMID 33318505›Full record

ArticleScientific reports2020

The role of microRNA-3085 in chondrocyte function.

Linh Le, Lingzi Niu, Matthew J Barter, David A Young, Tamas Dalmay, Ian M Clark, Tracey E Swingler

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.5field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Neonatal sepsis and Kawasaki disease.European journal of pediatrics · 2022
    Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Linh LeBiomedical Research Centre, School of Biological Sciences, Norwich Research Park, University of East Anglia, Norwich, NR4 7TJ, Norfolk, UK.
Lingzi NiuBiomedical Research Centre, School of Biological Sciences, Norwich Research Park, University of East Anglia, Norwich, NR4 7TJ, Norfolk, UK.
Matthew J BarterInstitute of Genetic Medicine, Newcastle University, Newcastle-upon-Tyne, UK.
David A YoungInstitute of Genetic Medicine, Newcastle University, Newcastle-upon-Tyne, UK.
Tamas DalmayBiomedical Research Centre, School of Biological Sciences, Norwich Research Park, University of East Anglia, Norwich, NR4 7TJ, Norfolk, UK.
Ian M ClarkBiomedical Research Centre, School of Biological Sciences, Norwich Research Park, University of East Anglia, Norwich, NR4 7TJ, Norfolk, UK. i.clark@uea.ac.uk.
Tracey E SwinglerBiomedical Research Centre, School of Biological Sciences, Norwich Research Park, University of East Anglia, Norwich, NR4 7TJ, Norfolk, UK.
Newcastle University · GBNorwich Research Park · GBUniversity of East Anglia · GBHo Chi Minh City Open University · VN

Funding

The Dunhill Medical Trust R371/0714The Dunhill Medical Trust R476/0516
6 · The paper itself

Abstract

MicroRNAs have been shown to play a role in cartilage development, homeostasis and breakdown during osteoarthritis. We previously identified miR-3085 in humans as a chondrocyte-selective microRNA, however it could not be detected by Northern blot. The aim of the current study was to prove that miR-3085 is a microRNA and to investigate the function of miR-3085 in signaling pathways relevant to cartilage homeostasis and osteoarthritis. Here, we confirm that miR-3085 is a microRNA and not another class of small RNA using (1) a pre-miR hairpin maturation assay, (2) expression levels in a Dicer null cell line, and (3) Ago2 pulldown. MicroRNA-3085-3p is expressed more highly in micromass than monolayer cultured chondrocytes. Transfection of miR-3085-3p into chondrocytes decreases expression of COL2A1 and ACAN, both of which are validated as direct targets of miR-3085-3p. Interleukin-1 induces the expression of miR-3085-3p, at least in part via NFκB. In a feed-forward mechanism, miR-3085-3p then potentiates NFκB signaling. However, at early time points after transfection, its action appears to be inhibitory. MyD88 has been shown to be a direct target of miR-3085-3p and may be responsible for the early inhibition of NFκB signaling. However, at later time points, MyD88 knockdown remains inhibitory and so other functions of miR-3085-3p are clearly dominant. TGFβ1 also induces the expression of miR-3085-3p, but in this instance, it exerts a feedback inhibition on signaling with SMAD3 and SMAD4 shown to be direct targets. This in vitro analysis shows that miR-3085-3p functions in chondrocytes to induce IL-1-signaling, reduce TGFβ1 signaling, and inhibit expression of matrix genes. These data suggest that miR-3085-3p has a role in chondrocyte function and could contribute to the process of osteoarthritis.

Indexed as

Gene Expression RegulationSignal TransductionAggrecansCell Line, TumorChondrocytesCollagen Type IIHumansMicroRNAsMyeloid Differentiation Factor 88ACAN protein, humanAggrecansCOL2A1 protein, humanCollagen Type IIMicroRNAsMIRN-3085 microRNA, humanMYD88 protein, humanMyeloid Differentiation Factor 88

Identifiers

PMID33318505
PMCPMC7736321
OpenAlexW3111136241

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.